DOES CAPTOPRIL LOWER BLOOD-PRESSURE IN ANEPHRIC PATIENTS

被引:12
作者
MANINTVELD, AJ
WENTING, GJ
SCHALEKAMP, MADH
机构
[1] Hypertension Unit, Department of Internal Medicine I, University Hospital Dijkzigt, Erasmus University, Rotterdam
关键词
D O I
10.1136/bmj.2.6198.1110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1110 / 1110
页数:1
相关论文
共 5 条
[1]   CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].
CASE, DB ;
ATLAS, SA ;
LARAGH, JH ;
SEALEY, JE ;
SULLIVAN, PA ;
MCKINSTRY, DN .
PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206
[2]   ESTIMATING RENIN PARTICIPATION IN HYPERTENSION - SUPERIORITY OF CONVERTING ENZYME-INHIBITOR OVER SARALASIN [J].
CASE, DB ;
WALLACE, JM ;
KEIM, HJ ;
WEBER, MA ;
DRAYER, JIM ;
WHITE, RP ;
SEALEY, JE ;
LARAGH, JH .
AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) :790-796
[3]   ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].
GAVRAS, H ;
BRUNNER, HR ;
TURINI, GA ;
KERSHAW, GR ;
TIFFT, CP ;
CUTTELOD, S ;
GAVRAS, I ;
VUKOVICH, RA ;
MCKINSTRY, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995
[4]  
THURSTON H, 1978, CIRCULATION RES, V42, P589
[5]  
TURINI GA, 1979, LANCET, V1, P1213